PATENT CLAIM ANALYSIS

Application Number: 15942345
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["540", "360000"]

Abstract:
A compound is represented as Formula I, a tautomer thereof, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof: Compounds of Formula I are inhibitors of N-acylethanolamine hydrolyzing acid amidase (NAAA).

Claim (Index 4):
The compound of  claim 1 , wherein:\n Z is NCS, \u2014(CH 2 ) 1-5 NCS, CN, \u2014(CH 2 ) 1-5 CN, or \u2014CR 1 R 2 CN, wherein R 1  and R 2  are H or form cyclopropyl; M is N or C; W is (CH 2 ) n , and n is 0, 1, or 2; D is a cycloalkyl, aryl, heterocyclyl, or heteroaryl; Y is O, (CH 2 ) n , O(CH 2 ) n , (CH 2 ) n O, NR 3 (CH 2 ) n , (CH 2 ) n NR 3 , where n is 0, 1, or 2, and R 3  is H or C 1 -C 4  alkyl; X is (CH 2 ) n , wherein n is 0, 1, or 2; B is (CH 2 ) n\u2032  wherein n\u2032 is 2, 3, or 4, cycloalkyl, heterocyclyl, aryl, heteroaryl; V is O, NR 5 , SO 2 , SO, CO, CONR 6 , CR 7 R 8 , or (CH 2 ) n , wherein R 6  is H or C 1 -C 4  alkyl; and R 7  and R 8  are each independently H, C 1 -C 4  alkyl, cycloalkyl, aryl, heterocyclyl, heteroaryl, or together with the C to which they are attached form a saturated or unsaturated ring; and A is cycloalkyl, aryl, heterocyclyl, heteroaryl.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 90.0
- Lexical Diversity: 1.31034
- Patent Class: 540.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15311817', '15253773', '14770331', '15763724', '14169770']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7369242781647425
- 35 USC 102 Novelty (BERT): 0.6095585330411059
- Combined Prediction Score: 0.7241877036523788
- Mean Citation Score: 384.380926
- Max Citation Score: 623.34186
- Similarity Product: 449.3282088734758

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test